Why choose Redica to stay on top of the ever-shifting global regulatory landscape?
Comprehensive Regulation and Standards’ monitoring to put the “c” in cGxP
In this demo you will dive into:
- Global GxP source coverage
- Enriched and searchable content
- Simple dashboard
- Integrated workflows for triage and impact assessments
Chosen by global leaders and innovators





Comprehensive regulatory monitoring
One Dashboard to simplify your life
Pull up the only feed you will need to stay on top of the incredibly complex and ever-shifting global regulatory landscape. Change your risk profile by dramatically reducing the risk of being unaware.

Get your arms around the world
External Monitoring includes data sets such as:
Go beyond keyword-based-search and tailor your experience using powerful Redica labels that include Industry, Scope (eg GLP, GMP, GCP, GMP for IMP etc), Source (eg EMA and US FDA).
Get the key topics that keep the Industry awake at night at your fingertips, with pre-triaged themes like Nitrosamines, Data Integrity, Cell & Gene Therapy, Cybersecurity, and much more.
Get Signals across the entire Regulation Lifecycle, from the early noise (eg agencies work plan, strategies, concept papers) all the way through Final Regulation and Enforcement.
“Big pharma” capability
at the push of a button
Discover how a recently approved for market therapeutic drug company leveraged Redica’s External Monitoring as a one-stop-shop to get ahead of the Business Development team and to stay prepared.
Challenge
The small quality team of 3 needed to ensure that it could understand and be in compliance with regulations from these new markets.
“We needed to get in front of the wave.”
Solution
Solution includes a simple dashboard that is tailored to individual needs so they only see pertinent and valuable information – no more sifting through the weeds and newsletters!
Impact
Team members now spend less than one hour per week to scan and triage all applicable regulatory change related to their product lines, and the time to impact was almost immediate.
“We get turn key big pharma tools and capabilities with minimal effort.”